TCM
TimesSquare Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-868,812
| Closed | -$62M | – | 233 |
|
|
2018
Q4 | $62M | Sell |
868,812
-87,700
| -9% | -$6.26M | 0.54% | 75 |
|
|
2018
Q3 | $118M | Sell |
956,512
-525,100
| -35% | -$64.6M | 0.78% | 32 |
|
|
2018
Q2 | $146M | Sell |
1,481,612
-318,450
| -18% | -$31.3M | 0.97% | 16 |
|
|
2018
Q1 | $149M | Sell |
1,800,062
-569,988
| -24% | -$47.3M | 1.02% | 15 |
|
|
2017
Q4 | $184M | Buy |
2,370,050
+21,950
| +0.9% | +$1.7M | 1.21% | 9 |
|
|
2017
Q3 | $144M | Buy |
2,348,100
+32,727
| +1% | +$2.01M | 0.96% | 16 |
|
|
2017
Q2 | $107M | Buy |
2,315,373
+1,735,700
| +299% | +$79.8M | 0.69% | 38 |
|
|
2017
Q1 | $25.1M | Buy |
579,673
+48,573
| +9% | +$2.1M | 0.16% | 199 |
|
|
2016
Q4 | $20.6M | Buy |
531,100
+27,800
| +6% | +$1.08M | 0.14% | 206 |
|
|
2016
Q3 | $25.5M | Buy |
503,300
+66,000
| +15% | +$3.34M | 0.16% | 198 |
|
|
2016
Q2 | $19.9M | Buy |
+437,300
| New | +$19.9M | 0.13% | 201 |
|